NCT05370300View on ClinicalTrials.gov

SNAPS Breast Cancer Patient Study Breast Cancer Patients

Not yet recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2027

Conditions

Breast CancerBreast Cancer Female

Interventions

DIAGNOSTIC_TEST

Blood test

Proprietary immunogenomic signature from peripheral blood CD14 and CD2 cells.

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

lead

Immunis.AI

INDUSTRY

NCT05370300 - SNAPS Breast Cancer Patient Study Breast Cancer Patients | Biotech Hunter | Biotech Hunter